What is scope of the report?

The base year for the study has been considered 2019, historic year 2014 and 2018. Read More

What are the significant segments operating in the market?

Market is segmented on the basis. Read More

What are the vital market dynamics?

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. Read More

What does a company profile includes?

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering. Read More

Global Radiopharmaceuticals/Nuclear Market by Type (Diagnostic, Therapeutic), procedure, Application, End User, Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2018 to 2025

Publish Date: Mar, 2019
Report ID: 376060
Category: Pharmaceutical
Pages: 0

$4700

Global radiopharmaceuticals/ nuclear medicine market is expected to reach USD 6.5 Billion in 2017 to USD 12.41 Billion by 2025 at a CAGR of 7.11% from 2018 to 2025. Increasing incidence of cancer and cardiovascular disorders and rising usage of clear imaging technique such as PET and SPECT are driving the growth of the market.

Market Overview:

Radiopharmaceuticals are formulations made up of radioactive isotopes. These have applications in diagnosis and therapeutics. They contain a radioactive substance which is used in the treatment of cancer and cardiac & neurological disorders. These are more convenient therapeutic radiopharmaceuticals for oncology and cancer treatment.

Moreover, these are a convenient and safer alternative for patients as compared to X-Rays and other external radiation imaging devices. Radiopharmaceuticals, also known as nuclear medicines are used in applications such as lymphoma and bone metastasis. F-18, Tc-99, Ga-67, and I-123 are some of the nuclear medicines used in diagnostic procedures while I-131, Ir-192, Y-90, and Ra-223 are used in therapeutics procedures.

Report Description:

The base year for the study has been considered 2017, the historic year 2015 and 2016 and, the forecast period considered is from 2018 to 2025. The radiopharmaceuticals/nuclear medicine market is analyzed by value (USD Billion).
The study delivers a comprehensive analysis of global radiopharmaceuticals/nuclear medicine market by type, procedure, application, end user and regions.
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2018 to 2025.
Porter’s Five Forces model is used to recognize the competitive scenario in the global radiopharmaceuticals/ nuclear medicine market. This report incorporates the industry analysis which is focused on providing an extensive view of the radiopharmaceuticals/ nuclear medicine market.
The study also includes attractiveness analysis of type, procedure, application, end user, and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
The report provides company profile of the key players operating in the radiopharmaceuticals/ nuclear medicine market and a comparative analysis based on their business overviews, product offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
The market estimates have been evaluated by considering the effect of different political, economic, social, technological and legal factors which are based on our extensive secondary research, primary research, and in-house databases.

Market Dynamics:

Drivers:

Increasing incidence and prevalence of target conditions
Alpha radio-immunotherapy-based targeted cancer treatment
Initiatives to lessen the demand-supply gap of isotopes

Restraints:

The short half-life of radiopharmaceuticals

Opportunities:

Use of radiopharmaceuticals in neurological applications

Challenges:

Hospital budget cuts and high equipment prices

Global Radiopharmaceuticals/ Nuclear Medicine Market Key Findings:

All the segments have been analyzed on global, regional and country basis. The study includes an analysis of more than 30 countries for each segment.

Segmentation Analysis:

The radiopharmaceuticals/nuclear medicine market is segmented by type, procedure, application, and end user.

The type segment is classified into diagnostic nuclear medicine and therapeutic nuclear medicine. Tc-99m accounted for the largest share of dominating 36.17% in 2017. Tc-99m is had applications in many diagnostic nuclear medicine procedures such as cardiac ventriculography, sentinel-node identification, functional brain imaging immunoscintigraphy, and other diagnosing various bone ailments. Increasing adoption in these procedures is driving the growth of the market.
Application segment is divided into diagnostic applications and therapeutic applications. The oncology is dominating and is expected to grow with the highest CAGR of 8.17% in the forecast period. Use of F-18 in oncology applications to analyze glucose metabolism in the heart, lungs, and brain in cancer diagnosis is a major reason for the segment growth. It also used in monitoring cancer treatment and stages, particularly colorectal cancer, NHL, melanoma, breast cancer, and lung cancer.
Procedure segment is classified into diagnostic procedures and therapeutic procedures. The diagnostic procedures segment is dominating and was valued at around USD 4.03 Billion in 2017. The rising prevalence of chronic disease is contributing to the growth of the market.
The end-user segment is bifurcated into hospitals and diagnostic centers and research institutes. The hospital's segment is dominating and was valued at around USD 8.17 Billion in 2017. Rising healthcare infrastructure in emerging economies and an increasing number of hospitals to cater to the demand are positively impacting the growth of the segment.

Regional Segmentation Analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and the Middle East and Africa. North America region dominated the global radiopharmaceuticals/nuclear medicine market and generated the largest revenue of USD 3.38 Billion in 2017 whereas the Asia Pacific is expected to register the highest growth in the forecast period.

North America region is expected to dominate the market due to advanced healthcare infrastructure in the region, especially in the U.S. Rising burden of cancer and various cardiovascular disorders are also supporting the market.
The Asia Pacific is expected to register the highest growth in the forecast period. Demand for nuclear medicine is increasing in emerging markets due to rising disposable income, improving healthcare standards and favorable reforms in foreign policies.

Global Radiopharmaceuticals/ Nuclear Medicine Market Competitive Analysis:

Major players operating in the radiopharmaceuticals/ nuclear medicine market are GE Healthcare, Eckert & Ziegler Group, Jubilant Life Sciences, Mallinckrodt Pharmaceuticals, Bracco Imaging S.p.A, Nordion, Inc., Australian Nuclear Science & Technology Organization, The Institute of Radioelements, Eczacibasi-Monrol, NTP Radioisotopes SOC Ltd., Cardinal Health, Curium, Bayer, Lantheus Medical Imaging and others. Market participants are engaged in various strategies to increase their footprints in the market. For instance, For instance, in August 2016, the Eckert & Ziegler Group acquired BR - 77 Comércio, Distribuidora e Transportes de Medicamentos Ltda based in Brazil. Through this acquisition, the company enhanced its footprints in South America.

This study forecasts revenue growth at global, regional, and country levels from 2015 to 2025. Fior Market Research has segmented the global radiopharmaceuticals/ nuclear medicine market by below-mentioned segments:

Global Radiopharmaceuticals/ Nuclear Medicine Market, By Type:

Diagnostic Nuclear Medicine
- Spect Radiopharmaceuticals
  - Tc-99m
  - Tl-201
  - Ga-67
  - I-123
  - Other Spect Isotopes
- Pet Radiopharmaceuticals
  - F-18
  - Ru-82
  - Other Pet Isotopes
Therapeutic Nuclear Medicine
- Alpha Emitters
  - Ra-223
- Beta Emitters
  - I-131
  - Y-90
  - Sm-153
  - Re-186
  - Lu-177
  - Other Beta Emitters
- Brachytherapy Isotopes
  - I-125
  - Ir-192
  - Pd-103
  - Cs-131
  - Other Brachytherapy Isotopes

Global Radiopharmaceuticals/ Nuclear Medicine Market, By Application:

Diagnostic Applications
- Spect Applications
  - Cardiology
  - Lymphoma
  - Neurology
  - Thyroid
  - Other Spect Applications
- Pet Applications
  - Oncology
  - Cardiology
  - Neurology
  - Other Pet Applications
Therapeutic Applications
- Thyroid
- Bone Metastasis
- Lymphoma
- Endocrine Tumors
- Other Therapeutic Applications

Global Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure:

Diagnostic Procedures
- Spect Radiopharmaceuticals
- Pet Radiopharmaceuticals
Therapeutic Procedures
- Beta Emitters
- Alpha Emitters
- Brachytherapy Isotopes

Global Radiopharmaceuticals/ Nuclear Medicine Market, By End User:

Hospitals and diagnostic centers
Research institutes

Global Radiopharmaceuticals/ Nuclear Medicine Market, By Regions:

North America
- The U.S.
- Canada
- Mexico
Europe
- Germany
- France
- Sweden
- Netherlands
- U.K.
- Italy
- Spain
- Turkey
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- South Korea
- Australia
- Singapore
- Malaysia
- Thailand
- Indonesia
- Philippines
- Rest of Asia-Pacific
South America
- Brazil
- Argentina
- Colombia
- Rest of South America
The Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of The Middle East and Africa

*All our reports are customizable as per customer requirements

Request Sample Request for Customization

1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market attractiveness analysis by type
4.3.2. Market attractiveness analysis by procedure
4.3.3. Market attractiveness analysis by application
4.3.4. Market attractiveness analysis by end user
4.3.5. Market attractiveness analysis by region
4.4. Industry Trends

5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. I. Increasing incidence and prevalence of target conditions
5.2.2. Alpha radio-immunotherapy-based targeted cancer treatment
5.2.3. Initiatives to lessen the demand-supply gap of isotopes
5.3. Restraints
5.3.1. Short half-life of radiopharmaceuticals
5.4. Opportunities
5.4.1. Use of radiopharmaceuticals in neurological applications
5.5. Challenges
5.5.1. Hospital budget cuts and high equipment prices

6. Global Radiopharmaceuticals/ Nuclear Medicine Market Analysis and Forecast, By Type
6.1. Segment Overview
6.2. Diagnostic Nuclear Medicine
6.3. Disposables
6.3.1. Spect Radiopharmaceuticals
6.3.1.1. Tc-99m
6.3.1.2. Tl-201
6.3.1.3. Ga-67
6.3.1.4. I-123
6.3.1.5. Other Spect Isotopes
6.3.2. Pet Radiopharmaceuticals
6.3.2.1. F-18
6.3.2.2. Ru-82
6.3.2.3. Other Pet Isotopes
6.4. Therapeutic Nuclear Medicine
6.4.1. Alpha Emitters
6.4.1.1. Ra-223
6.4.2. Beta Emitters
6.4.2.1. I-131
6.4.2.2. Y-90
6.4.2.3. Sm-153
6.4.2.4. Re-186
6.4.2.5. Lu-177
6.4.2.6. Other Beta Emitters
6.4.3. Brachytherapy Isotopes
6.4.3.1. I-125
6.4.3.2. Ir-192
6.4.3.3. Pd-103
6.4.3.4. Cs-131
6.4.3.5. Other Brachytherapy Isotopes

7. Global Radiopharmaceuticals/ Nuclear Medicine Market Analysis and Forecast, By Application
7.1. Segment Overview
7.2. Diagnostic Applications
7.2.1. Spect Applications
7.2.1.1. Cardiology
7.2.1.2. Lymphoma
7.2.1.3. Neurology
7.2.1.4. Thyroid
7.2.1.5. Other Spect Applications
7.2.2. Pet Applications
7.2.2.1. Oncology
7.2.2.2. Cardiology
7.2.2.3. Neurology
7.2.2.4. Other Pet Applications
7.3. Therapeutic Applications
7.3.1. Thyroid
7.3.2. Bone Metastasis
7.3.3. Lymphoma
7.3.4. Endocrine Tumors
7.3.5. Other Therapeutic Applications

8. Global Radiopharmaceuticals/ Nuclear Medicine Market Analysis and Forecast, By Procedure
8.1. Segment Overview
8.2. Diagnostic Procedure
8.2.1. Spect Radiopharmaceuticals
8.2.2. Pet Radiopharmaceuticals
8.3. Therapeutic Procedures
8.3.1. Beta Emitters
8.3.2. Alpha Emitters
8.3.3. Brachytherapy Isotopes

9. Global Radiopharmaceuticals/ Nuclear Medicine Market Analysis and Forecast, By End User
9.1. Segment Overview
9.2. Hospitals and diagnostic centers
9.3. Research institutes

10. Global Radiopharmaceuticals/ Nuclear Medicine Market Analysis and Forecast, By Regional Analysis
10.1. Segment Overview
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.2.3. Mexico
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. Sweden
10.3.4. Netherlands
10.3.5. U.K.
10.3.6. Italy
10.3.7. Spain
10.3.8. Turkey
10.3.9. Switzerland
10.3.10. Belgium
10.3.11. Rest of Europe
10.4. Asia-Pacific
10.4.1. Japan
10.4.2. China
10.4.3. India
10.4.4. South Korea
10.4.5. Australia
10.4.6. Singapore
10.4.7. Malaysia
10.4.8. Thailand
10.4.9. Indonesia
10.4.10. Philippines
10.4.11. Rest of Asia-Pacific
10.5. South America
10.5.1. Brazil
10.5.2. Argentina
10.5.3. Colombia
10.5.4. Rest of South America
10.6. The Middle East and Africa
10.6.1. Saudi Arabia
10.6.2. UAE
10.6.3. Egypt
10.6.4. Nigeria
10.6.5. South Africa
10.6.6. Rest of the Middle East and Africa

11. Global Radiopharmaceuticals/ Nuclear Medicine Market-Competitive Landscape
11.1. Overview
11.2. Market Share of Key Players in the Radiopharmaceuticals/ Nuclear Medicine Market
11.2.1. Global Company Market Share
11.2.2. North America Company Market Share
11.2.3. Europe Company Market Share
11.2.4. APAC Company Market Share
11.3. Competitive Situations and Trends
11.3.1. Product Launches and Developments
11.3.2. Partnerships, Collaborations, and Agreements
11.3.3. Mergers & Acquisitions
11.3.4. Expansions

12. Company Profiles
12.1. GE Healthcare
12.1.1. Business Overview
12.1.2. Company Snapshot
12.1.3. Company Market Share Analysis
12.1.4. Company Product Portfolio
12.1.5. Recent Developments
12.1.6. SWOT Analysis
12.2. Eckert & Ziegler Group
12.2.1. Business Overview
12.2.2. Company Snapshot
12.2.3. Company Market Share Analysis
12.2.4. Company Product Portfolio
12.2.5. Recent Developments
12.2.6. SWOT Analysis
12.3. Jubilant Life Sciences
12.3.1. Business Overview
12.3.2. Company Snapshot
12.3.3. Company Market Share Analysis
12.3.4. Company Product Portfolio
12.3.5. Recent Developments
12.3.6. SWOT Analysis
12.4. Mallinckrodt Pharmaceuticals
12.4.1. Business Overview
12.4.2. Company Snapshot
12.4.3. Company Market Share Analysis
12.4.4. Company Product Portfolio
12.4.5. Recent Developments
12.4.6. SWOT Analysis
12.5. Bracco Imaging S.p.A
12.5.1. Business Overview
12.5.2. Company Snapshot
12.5.3. Company Market Share Analysis
12.5.4. Company Product Portfolio
12.5.5. Recent Developments
12.5.6. SWOT Analysis
12.6. Nordion, Inc.
12.6.1. Business Overview
12.6.2. Company Snapshot
12.6.3. Company Market Share Analysis
12.6.4. Company Product Portfolio
12.6.5. Recent Developments
12.6.6. SWOT Analysis
12.7. NTP Radioisotopes SOC Ltd.
12.7.1. Business Overview
12.7.2. Company Snapshot
12.7.3. Company Market Share Analysis
12.7.4. Company Product Portfolio
12.7.5. Recent Developments
12.7.6. SWOT Analysis
12.8. Cardinal Health
12.8.1. Business Overview
12.8.2. Company Snapshot
12.8.3. Company Market Share Analysis
12.8.4. Company Product Portfolio
12.8.5. Recent Developments
12.8.6. SWOT Analysis
12.9. Curium
12.9.1. Business Overview
12.9.2. Company Snapshot
12.9.3. Company Market Share Analysis
12.9.4. Company Product Portfolio
12.9.5. Recent Developments
12.9.6. SWOT Analysis
12.10. Bayer
12.10.1. Business Overview
12.10.2. Company Snapshot
12.10.3. Company Market Share Analysis
12.10.4. Company Product Portfolio
12.10.5. Recent Developments
12.11. Lantheus Medical Imaging
12.11.1. Business Overview
12.11.2. Company Snapshot
12.11.3. Company Market Share Analysis
12.11.4. Company Product Portfolio
12.11.5. Recent Developments
12.12. The Institute of Radioelements
12.12.1. Business Overview
12.12.2. Company Snapshot
12.12.3. Company Market Share Analysis
12.12.4. Company Product Portfolio
12.12.5. Recent Developments
12.13. Australian Nuclear Science & Technology Organization
12.13.1. Business Overview
12.13.2. Company Snapshot
12.13.3. Company Market Share Analysis
12.13.4. Company Product Portfolio
12.13.5. Recent Developments
12.14. Eczacibasi-Monrol
12.14.1. Business Overview
12.14.2. Company Snapshot
12.14.3. Company Market Share Analysis
12.14.4. Company Product Portfolio
12.14.5. Recent Developments

List of Table
1. Global Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
2. Global Radiopharmaceuticals/ Nuclear Medicine Machine Market, By Diagnostic Nuclear Medicine, 2015–2025 (USD Billion)
3. Global Radiopharmaceuticals/ Nuclear Medicine Market, By Therapeutic Nuclear Medicine, 2015–2025 (USD Billion)
4. Global Diagnostic Nuclear Medicine Market, By Region, 2015–2025 (USD Billion)
5. Global Therapeutic Radiopharmaceuticals/ Nuclear Medicine Market, By Region, 2015–2025 (USD Billion)
6. Global Radiopharmaceuticals/ Nuclear Medicine Market, By Application, 2015–2025 (USD Billion)
7. Global Radiopharmaceuticals/ Nuclear Medicine Market, By Diagnostic Applications, 2015–2025 (USD Billion)
8. Global Radiopharmaceuticals/ Nuclear Medicine Market, By Therapeutic Applications, 2015–2025 (USD Billion)
9. Global Diagnostic Applications Radiopharmaceuticals/ Nuclear Medicine Market, BY Region, 2015–2025 (USD Billion)
10. Global Therapeutic Applications Radiopharmaceuticals/ Nuclear Medicine Market, By Region, 2015–2025 (USD Billion)
11. Global Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
12. Global Diagnostic Procedures Radiopharmaceuticals/ Nuclear Medicine Market, By Region, 2015–2025 (USD Billion)
13. Global Therapeutic Procedures Radiopharmaceuticals/ Nuclear Medicine Market, By Region, 2015–2025 (USD Billion)
14. Global Radiopharmaceuticals/ Nuclear Medicine Market, By End User, 2015–2025 (USD Billion)
15. Global Hospitals and diagnostic centers Radiopharmaceuticals/ Nuclear Medicine Market, By Region, 2015–2025 (USD Billion)
16. Global Research institutes Radiopharmaceuticals/ Nuclear Medicine Market, By Region, 2015–2025 (USD Billion)
17. Global Therapeutic Procedures Radiopharmaceuticals/ Nuclear Medicine Market, By Region, 2015–2025 (USD Billion)
18. North America Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
19. North America Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
20. North America Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
21. North America Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
22. U.S. Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
23. U.S. Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
24. U.S. Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
25. U.S. Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
26. Canada Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
27. Canada Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
28. Canada Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
29. Canada Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
30. Mexico Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
31. Mexico Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
32. Mexico Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
33. Mexico Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
34. Europe Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
35. Europe Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
36. Europe Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
37. Europe Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
38. Germany Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
39. Germany Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
40. Germany Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
41. Germany Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
42. France Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
43. France Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
44. France Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
45. France Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
46. Sweden Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
47. Sweden Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
48. Sweden Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
49. Sweden Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
50. Netherlands Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
51. Netherlands Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
52. Netherlands Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
53. Netherlands Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
54. U.K. Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
55. U.K. Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
56. U.K. Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
57. U.K. Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
58. Italy Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
59. Italy Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
60. Italy Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
61. Italy Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
62. Spain Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
63. Spain Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
64. Spain Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
65. Spain Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
66. Turkey Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
67. Turkey Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
68. Turkey Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
69. Turkey Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
70. Switzerland Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
71. Switzerland Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
72. Switzerland Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
73. Switzerland Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
74. Belgium Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
75. Belgium Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
76. Belgium Radiopharmaceuticals/ Nuclear Medicine Market, By Application, 2015–2025 (USD Billion)
77. Belgium Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
78. Asia Pacific Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
79. Asia Pacific Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
80. Asia Pacific Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
81. Asia Pacific Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
82. Japan Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
83. Japan Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
84. Japan Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
85. Japan Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
86. China Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
87. China Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
88. China Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
89. China Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
90. China Radiopharmaceuticals/ Nuclear Medicine Market, By Application, 2015–2025 (USD Billion)
91. China Radiopharmaceuticals/ Nuclear Medicine Market, By End User, 2015–2025 (USD Billion)
92. India Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
93. India Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
94. India Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
95. India Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
96. South Korea Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
97. South Korea Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
98. South Korea Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
99. South Korea Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
100. Australia Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
101. Australia Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
102. Australia Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
103. Australia Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
104. Singapore Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
105. Singapore Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
106. Singapore Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
107. Singapore Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
108. Malaysia Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
109. Malaysia Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
110. Malaysia Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
111. Malaysia Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
112. Thailand Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
113. Thailand Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
114. Thailand Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
115. Thailand Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
116. Indonesia Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
117. Indonesia Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
118. Indonesia Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
119. Indonesia Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
120. Philippines Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
121. Philippines Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
122. Philippines Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
123. Philippines Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
124. South America Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
125. South America Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
126. South America Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
127. South America Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
128. Brazil Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
129. Brazil Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
130. Brazil Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
131. Brazil Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
132. Argentina Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
133. Argentina Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
134. Argentina Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
135. Argentina Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
136. Colombia Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
137. Colombia Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
138. Colombia Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
139. Colombia Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
140. Middle East and Africa Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
141. Middle East and Africa Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
142. Middle East and Africa Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
143. Middle East and Africa Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
144. Saudi Arabia Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
145. Saudi Arabia Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
146. Saudi Arabia Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
147. Saudi Arabia Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
148. UAE Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
149. UAE Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
150. UAE Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
151. UAE Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
152. Egypt Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
153. Egypt Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
154. Egypt Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
155. Egypt Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
156. Nigeria Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
157. Nigeria Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
158. Nigeria Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
159. Nigeria Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)
160. South Africa Radiopharmaceuticals/ Nuclear Medicine Market, By Type, 2015–2025 (USD Billion)
161. South Africa Radiopharmaceuticals/ Nuclear Medicine Market, By Procedure, 2015–2025 (USD Billion)
162. South Africa Radiopharmaceuticals/ Nuclear Medicine Market, By Application 2015–2025 (USD Billion)
163. South Africa Radiopharmaceuticals/ Nuclear Medicine Market, By End User 2015–2025 (USD Billion)

List of Figures
1. Global Radiopharmaceuticals/ Nuclear Medicine Market Segmentation
2. Radiopharmaceuticals/ Nuclear Medicine Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Radiopharmaceuticals/ Nuclear Medicine Market attractiveness analysis by Type
9. Global Radiopharmaceuticals/ Nuclear Medicine Market attractiveness analysis by Procedure
10. Global Radiopharmaceuticals/ Nuclear Medicine Market attractiveness analysis by Application
11. Global Radiopharmaceuticals/ Nuclear Medicine Market attractiveness analysis by End User
12. Global Radiopharmaceuticals/ Nuclear Medicine Market attractiveness analysis by Region
13. Global Radiopharmaceuticals/ Nuclear Medicine Market: Dynamics
14. Global Radiopharmaceuticals/ Nuclear Medicine Market Share by Type (2017 & 2025)
15. Global Radiopharmaceuticals/ Nuclear Medicine Market Share by Procedure (2017 & 2025)
16. Global Radiopharmaceuticals/ Nuclear Medicine Market Share by Application (2017 & 2025)
17. Global Radiopharmaceuticals/ Nuclear Medicine Market Share by End User (2017 & 2025)
18. Global Radiopharmaceuticals/ Nuclear Medicine Market Share by Regions (2017 & 2025)
19. Global Radiopharmaceuticals/ Nuclear Medicine Market Share by Company (2018)

Research Methodology

Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.

Market research is valuable because of the following reasons:

Market research helps businesses strengthen a company’s position
Market research helps in minimizing the investment risks associated with the businesses in any industry vertical
Market research helps in identifying the potential threats and opportunities associated with the business industry
Market research aids in spotting the emerging trends and facilitates strategic planning in order to stay ahead in the competition

Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.

Our market research process involves with the four specific stages.

Data Collection
Data Synthesis
Market Deduction & Formulation
Data Screening & Validation

Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:

Primary Research: By conducting primary research, it involves with the two types of data gathering; exploratory and specific. Exploratory data is open-ended and helps us to define a particular problem involving surveys, and pilot study to the specific consumer group, knowing their needs and wants catering to the industry related product/service offering. Explanatory data gathering follows with the bit of unstructured way. Our analyst group leads the study by focusing on the key crowd, in this manner picking up bits of knowledge from them. In light of the points of view of the clients, this data is used to plan advertise techniques. In addition, showcase overviews causes us to comprehend the current scenario of the business. Specific data gathering on the hand, involves with the more structured and formal way. The primary research usually includes in telephonic conversations, E-mail collaborations and up close and personal meetings/interviews with the raw material suppliers, industrial wholesalers, and independent consultants/specialists. The interviews that we conduct offers important information on showcase size and industry development patterns. Our company likewise conducts interviews with the different business specialists so as to increase generally bits of knowledge of the business/showcase.
Secondary Research: The secondary research incorporates with the data gathering from the non-profit associations and organizations, for example, World bank, WHO, investor relations and their presentations, statistical databases, yearly(annual reports) reports, national government records, factual databases, websites, articles, white papers, press releases, blogs and others. From the annual report, we deduce an organization's income/revenue generation to comprehend the key product segment related to the market. We examine the organization sites and implement product mapping strategy which is significant for determining the segment revenue. In the product mapping technique, we choose and categorize the products offered by the companies catering to the industry specific market, derive the segment revenue for each of the organizations to get the market estimation. We also gather data & Information based on the supply and demand side of the value chain involved with the domain specific market. The supply side denotes the distributors, wholesalers, suppliers and the demand side denotes the end-consumers/customers of the value chain. The supply side of the market is analyzed by examining the product growth across industry in each of the region followed by its pricing analysis. The demand side is analyzed by the evaluating the penetration level and adoption rates of the product by referring to the historical/past data, examine the present usage and forecasting the future trends.
Purchased Database: Our purchased data provides insights about the key market players/companies along with their financial analysis. Additionally, our data base also includes market related information.

We also have the agreements with various reputed data providers, consultants and third party vendors who provide information which are not limited to:

Export & Import Data
Business Information related to trade and its statistics
Penetration level of a particular product/service based on geography mainly focusing on the unmet prerequisites of the customers.

In-house Library: Apart from these third-party sources, we have our in-house library of quantitative and qualitative data & information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, internal audit reports, historic databases, archives and journal publications. Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those particular cases, we utilize our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopts a robust research technique in order to deduce the market size and its estimates:
Examining demographic along with psychographic segmentation for market evaluation
Analyzing the macro and micro-economic indicators for each demography
Evaluating the current industry trends popular in the market.

Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:

Information Screening: Information screening is the way toward examining information/data gathered from the sources for errors/mistakes and amending it before data integration process. The screening includes in looking at raw information, identifying and distinguishing mistakes and managing missing information. The reason for the information screening is to ensure information is effectively entered or not. Our organization utilizes objective and precise information screening grades through repetitive quality checks.
Data Integration: The data integration method involves with the incorporation of numerous information streams. The data streams is important so as to deliver investigate examines that give overall market scenario to the investors. These information streams originate from different research contemplates and our in house database. After the screening of the information, our analysts conduct efficient integration of the data streams, optimizing connections between integrated surveys and syndicated data sources. There are two research approaches that we follow so as to coordinate our information; top down methodology and bottom up methodology.

Top-down analysis generally refers to using broad factors as a basis for decision making. The top-down approach helps in identifying the overall market scenario along with the external and internal factors effecting the market growth.

The bottom-up approach takes a completely different approach. Generally, the bottom-up approach focuses its analysis on micro attributes and specific characteristics of the domain specific market.

Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.

This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.

Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.

Please fill the form below, to recieve the report sample

Full Name

Country

Phone

Company

Designation

Comment

Human Verification

Our Clients

Choose License Type

For more information

Have a Question? Email us at

sales@fiormarkets.com

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

Testimonials

Hi John,
Thanks for the report. We've been going through it and see some good data on the market and players. –

Kennedy Brown
Health Technology Innovation
United States

Hi Rahul,
Thank You for the report it is good and beneficial for me.
Thank You in Advance

Mika Salomäki

Dear Siddhartha,
Thank you for your fast reply. The report arrived safe and sound, evrything looks all right.
Thank you very much for your assitance and I will be looking forward to another opportunity for cooperation.

ONDŘEJ ŠUPKA
Analytics Department
ČESKÁ ZBROJOVKA A.S.

Dear Siddhartha,
The report looks good, and we believe the material mix is more realistic now. It is good to know you report “Net” Manufacturing Selling Price, as that can make a difference in how we view the numbers. The reports were great and we appreciate your working with us.
Thanks for all your help!